You searched for Parkinson's - Page 6 of 19

20S proteasome activation: Berlin biotech Booster Therapeutics secures $15 million for innovative therapies to tackle neurodegenerative diseases

News and Trends 15 Oct 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

…like Parkinson’s and Alzheimer’s. “We’re starting in neurodegenerative diseases, such as Parkinson’s and Alzheimer’s. We know that proteasome dysfunction is present in these diseases, and multiple pathways are going wrong,…

October 15, 2024 - 6 minutesmins - By Jules Adam

Best in Biotech 25 Jun 2024

Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024

…Parkinson’s disease and other neurodegenerative disorders. Inhibikase’s work is based on targeting Abelson tyrosine kinases (c-Abl), which play an important role in neurodegeneration. Inhibikase employs its proprietary RAMP (Re-engineering Approach…

June 25, 2024 - 7 minutesmins - By Jules Adam

Best in Biotech 13 Feb 2025

Seven companies using metabolomics to decode biology

…its lead program. Sinopia Biosciences Disease area: Parkinson’s disease Candidate: SB-0110 Recent news: Received 2 SBIR grants in 2024 Sinopia Biosciences leverages its proprietary artificial intelligence and machine learning (AI/ML)…

February 13, 2025 - 9 minutesmins - By Jules Adam

News and Trends 15 Jan 2018

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

…blood-brain barrier. Neurodegenerative diseases are a hot topic, with age-related diseases like Alzheimer’s and Parkinson’s rising in prevalence. In the US alone, 5 million people suffer from Alzheimer’s disease, 1…

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 12 Dec 2024

Top biotech deals of November 2024

…roll Partnerships focused on small molecules continue to be forged this month. U.S.-based Vesalius has partnered with GSK to develop small molecule inhibitor drugs for Parkinson’s disease. Vesalius will leverage…

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

Podcast 12 Jan 2024

Could natural killer cells transform Alzheimer’s treatment?

…a few years ago, I think that will still be pretty dramatic.” Song said there are no side effects with the process. Future plans: NK cells for Parkinson’s disease and…

January 12, 2024 - 6 minutesmins - By Jim Cornall

In Depth 8 Feb 2021

How Next-Generation Gene Therapy Tackles Complex Diseases

…approach could be extended to other conditions involving the brain, such as Parkinson’s, ALS and pain. However, this kind of research is still at an early stage and it will…

February 8, 2021 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Mar 2023

€260M fund addresses dementia investment shortfall

…and Parkinson’s disease. Last year, it was also awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The others are AviadoBio (frontotemporal dementia (FTD)…

March 31, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 16 Dec 2024

10 biotech companies to watch in 2025

…designation for Rett syndrome, fragile X syndrome, and infantile spasms A neuroscience company, Anavex Life Sciences, is developing small-molecule treatments for CNS disorders like Alzheimer’s disease, Parkinson’s disease, and Rett…

December 16, 2024 - 14 minutesmins - By Willow Shah-Neville

News and Trends 8 Dec 2016

Meet the Newest ALS Pioneer Company from Switzerland

…company are Neurimmune, a biotech from Zurich that uses high throughput technology to develop treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, and TVM Capital Life Science. Located in Switzerland,…

December 8, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jun 2018

Cambridge Biotech Raises €32M Series A Round to Treat Chronic Inflammation

…A round in 2016 to develop treatments for Alzheimer’s, Parkinson’s, heart disease and cancer. While chronic inflammation may sound like a small inconvenience, it can result in serious conditions like…

June 25, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 19 Dec 2016

Evotec closes the year partnering with Celgene to treat Alzheimer’s

…into solid tumors, inflammatory diseases, and now neurodegenerative conditions, which will include Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS) among others. With these ambitious targets, both Celgene and Evotec could…

December 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Booster launches to treat neurodegenerative diseases with proteasome activation

Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024

Seven companies using metabolomics to decode biology

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

Top biotech deals of November 2024

Could natural killer cells transform Alzheimer’s treatment?

How Next-Generation Gene Therapy Tackles Complex Diseases

€260M fund addresses dementia investment shortfall

10 biotech companies to watch in 2025

Meet the Newest ALS Pioneer Company from Switzerland

Cambridge Biotech Raises €32M Series A Round to Treat Chronic Inflammation

Evotec closes the year partnering with Celgene to treat Alzheimer’s

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!